Histamine production

Food-triggered flushing, bloating, or diarrhea can have several causes. Histamine made by gut bacteria is one possibility being studied. This stool marker estimates the microbial community's genetic capacity to produce it.

This is a research-stage measurement. There are no established clinical cutpoints, and using the result to choose treatment has not been shown to improve health outcomes. A higher value cannot establish histamine intolerance, food allergy, or bowel inflammation.

What the Result Represents

The test analyzes microbial DNA in stool using shotgun metagenomic sequencing. This approach reads DNA across the microbial community and identifies genes involved in functions such as histamine production. The result reflects the relative abundance of the relevant genetic machinery.

Genetic capacity differs from active production. The result does not measure how actively those genes are being used, how much histamine bacteria release, or how much reaches your circulation. It also isn't a count of histamine-producing bacteria. Food availability, bacterial strains, and conditions in the gut can affect what those genes do.

Where Gut Histamine Comes From

Histamine is a chemical messenger involved in immune reactions and gut movement. Histidine is one of the building blocks of protein. Both human cells and certain bacteria can turn histidine into histamine.

Mast cells are immune cells that store and release histamine. They are present in the gut lining, where allergic reactions can trigger its release. In a small study of people with food allergy, placing a food allergen against the small-intestine lining caused rapid histamine release and fluid secretion. That finding concerns the body's immune response, separate from bacterial production.

A genomic survey identified 117 bacterial species with predicted histamine-producing capacity. Those predictions came from genetic sequences, and production can differ between strains of the same species. Finding a species name alone doesn't establish that its members in your sample are actively making histamine.

Histamine exposure also depends on breakdown. Diamine oxidase, or DAO, is an enzyme involved in breaking down histamine in the intestine. Another enzyme handles histamine inside cells. Dietary intake, bacterial activity, immune-cell release, and breakdown all contribute to the amount your tissues encounter.

Histamine Intolerance

Histamine intolerance describes suspected adverse reactions to histamine in food. Reported symptoms include flushing, headaches, hives, and diarrhea, but these overlap with allergy, irritable bowel syndrome, and other conditions. Impaired histamine breakdown is a proposed explanation; the diagnosis cannot be established by a single blood or stool result.

One small study compared 12 women diagnosed with histamine intolerance with 14 healthy volunteers. Several bacterial groups containing histamine-producing strains were more abundant in the symptomatic group. The researchers profiled bacteria using 16S sequencing. This method identifies bacterial groups from a marker gene, so the findings concern community composition rather than this functional gene measurement.

Stool histamine concentrations did not differ significantly between the groups. That does not reveal whether histamine was absorbed or broken down differently. The study captured one point in time and could not establish whether the bacterial differences contributed to symptoms or followed changes in diet or health.

Irritable Bowel Syndrome

Experiments using gut microbes from people with irritable bowel syndrome, or IBS, provide a plausible link between bacterial histamine and abdominal pain. Transferring microbes from selected donors into mice increased the animals' sensitivity to intestinal pain. Further experiments implicated bacterial histamine and identified a histamine-producing strain of Klebsiella aerogenes as an important source.

The causal experiments were performed in mice. They support a mechanism that may matter in some human IBS cases, but they do not establish a stool genetic-capacity result that diagnoses IBS or predicts which treatment will help.

Histamine-Producing Bacteria Are Not Uniformly Harmful

Histamine's effects depend on where it acts and which receptors it activates. Receptors allow cells to respond to chemical signals. In experiments on cultured human immune cells, histamine made by Lactobacillus reuteri 6475 reduced an inflammatory signal. This is laboratory evidence, not proof that taking that strain treats symptoms. It does show why all histamine-producing bacteria cannot be assigned the same biological effect.

Inflammation and Gut Infections

Analyses of stool microbial DNA have found greater histamine-producing potential in people with inflammatory bowel disease, including Crohn's disease and ulcerative colitis. These are associations. They do not establish whether bacterial histamine contributes to inflammation or whether the altered gut environment favors bacteria carrying those genes.

A separate small study found higher stool histamine and lower histidine in children with diarrhea caused by disease-causing E. coli. It measured chemicals in stool, a different measurement from bacterial genetic capacity. The findings do not establish which organisms produced the histamine or how this test would change during an infection.

Changes Over Time

A study following 86 adults for up to six years found persistent personal features in their gut communities alongside changes over time. It studied the microbiome broadly and did not validate histamine-production trends. A falling result has not been established as evidence that symptoms, intestinal inflammation, or long-term health have improved.

When Results Can Be Misleading

• Relative abundance: A change in the proportion of function-associated genes can reflect changes elsewhere in the community, even without a matching change in their absolute amount.
• Stool versus the gut lining: Stool represents material leaving the intestine. It does not directly measure histamine release from immune cells or sample conditions throughout the small intestine.
• Medicines and recent illness: Antibiotics, acid-suppressing medicines, and gastrointestinal illness can alter the microbial community. Their effects on this particular score do not have a predictable direction.
• Collection and analysis: Contamination, storage conditions, DNA processing, and analysis methods can affect the result. Values from different laboratories or analysis pipelines are not automatically interchangeable.